Matthew Kirkpatrick

Professor with expertise in behavioral pharmacology and the social contexts of drug use, Dr. Matthew Kirkpatrick is an Associate Professor of Research in the Department of Population and Public Health Sciences at the Keck School of Medicine, University of Southern California. As the head of the Drug Use & Behavior Laboratory (DUB Lab), Dr. Kirkpatrick is at the forefront of research into the intricate social dynamics that influence drug use, focusing on substances such as stimulants, cannabis, alcohol, and tobacco. Dr. Kirkpatrick's research is distinguished by its innovative use of methodologies such as Ecological Momentary Assessment and comprehensive survey techniques. These approaches allow him to delve into the nuanced ways in which social influences, including the roles of friends and family, affect individual drug use patterns. His work is pivotal in understanding the complexities of problematic drug use and the factors that contribute to successful cessation outcomes. He earned his Ph.D. in Psychology from Columbia University, where he developed a strong foundation in behavioral science. Following this, Dr. Kirkpatrick completed postdoctoral training in neuropsychopharmacology at the University of Chicago, further honing his expertise in the neurological underpinnings of drug use behaviors. Dr. Kirkpatrick's contributions to the field are not only academic but also practical, as his research findings have significant implications for public health strategies and interventions aimed at reducing drug-related harm. His work is instrumental in shaping policies and programs that address the social determinants of health related to substance use. In addition to his research, Dr. Kirkpatrick is committed to mentoring the next generation of scientists and public health professionals. He actively engages with students and colleagues, fostering an environment of collaboration and innovation within the Keck School of Medicine. His dedication to education and research excellence makes him a respected figure in the field of public health and behavioral pharmacology.